Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics, PennyMac Financial, Dave & Buster's, Neumora Therapeutics, Extra Space Storage, & W. P. Carey. See full list here.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
UBS slashed the price target for Sunrun Inc.
(NASDAQ:RUN) from $23 to $20.
UBS analyst Jon Windham maintained a Buy rating.
Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts ORCL PT, Needham raises APLD…
Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downgrades. View complete details…
Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upgrades/downgrades, on…
Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst ratings page. Barclays, Wells…
Wall Street analysts changed outlook on top names, see all changes on analyst ratings page. Price targets raised for…
Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst ratings page for complete view.
